Its positive correlation with tumor purity and negative associations with CD8+ T cell and DC infiltration suggest its role in promoting an immune-excluded TME, a phenotype linked to poor prognosis and treatment resistance [35,36]. The gene discussed is CD8A; the disease is neoplasm.